Zymeworks ZYME Available-for-Sale Debt Securities
Available-for-Sale Debt Securities at other companies
Other financials
Where this comes from
Reported directly by Zymeworks in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent.
The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zymeworks's available-for-sale debt securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zymeworks's available-for-sale debt securities?
- Zymeworks (ZYME) reported available-for-sale debt securities of $120.45M in Q1 2026.
- How has Zymeworks's available-for-sale debt securities changed year-over-year?
- Zymeworks's available-for-sale debt securities decreased by 36.3% year-over-year, from $189.08M to $120.45M.
- What is the long-term trend for Zymeworks's available-for-sale debt securities?
- Over 2 years (2023 to 2025), Zymeworks's available-for-sale debt securities has grown at a -7.0% compound annual growth rate (CAGR), from $216.77M to $187.64M.
- What does available-for-sale debt securities mean?
- This metric represents the fair value of debt securities held by the company that are classified as available-for-sale. These investments serve as a liquid reserve of capital, with unrealized gains or losses recorded in other comprehensive income rather than net income. It reflects the company's strategy for managing excess cash and short-term liquidity through interest-bearing instruments.